We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Outline
- Historical perspective on current drugs for TB
- TB timeline
- Timeline: drugs for TB
- Timeline: TB treatment development
- Drugs for TB (WHO guidelines 2008) (1)
- Drugs for TB (WHO guidelines 2008) (2)
- Current regimens for treatment of TB
- Latent versus active TB (1)
- Recommended treatment regimens
- Recommended 1st line regimen
- Drug dosing (1)
- Drug dosing (2)
- Dosing frequency for new TB patients
- Dosing frequency
- Practical aspects of dosing
- Sputum monitoring during treatment
- Latent versus active TB (2)
- Latent disease - treatment
- Treatment principles
- Extended multidrug therapy to cure TB (1)
- Extended multidrug therapy to cure TB (2)
- Drug profiles
- Mechanism of action of 1st line drugs (1)
- Mechanism of action of 1st line drugs (2)
- Mechanism of action of 1st line drugs (3)
- Isoniazid
- Rifampicin
- Pyrazinamide
- Ethambutol
- Streptomycin
- Limitations of current therapy and special cases
- Efficacy vs. effectiveness
- Adherence
- Summary of adverse events by drug
- Side effects (minor)
- Side effects (may be major)
- Side effects (major)
- Liver toxicity
- Management of severe liver toxicity (1)
- Management of severe liver toxicity (2)
- Management of severe liver toxicity (3)
- Drug resistance
- Special situations
- Special situations: extrapulmonary TB
- Special situations: pregnancy and children
- Special situations: liver/kidney disease
- Special situations: HIV
- Summary
- Acknowledgements
Topics Covered
- Historical perspective
- Timeframe for drug and regimen development
- Current regimens
- Current WHO and ATS guidelines
- Treatment principles
- Pathological basis of action of TB drugs
- Drug profiles
- Limitations of current treatment regimens & special situations
- Problems with first line therapy
- Brief consideration of drug resistance
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Singh, K. (2013, July 11). Current drugs for TB treatment [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 7, 2024, from https://doi.org/10.69645/PNJK7115.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Kasha Singh has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.